A Common Nonsynonymous Single Nucleotide Polymorphism in the SLC30A8 Gene Determines ZnT8 Autoantibody Specificity in Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—Zinc transporter eight (SLC30A8) is a major target of autoimmunity in human type 1A diabetes and is implicated in type 2 diabetes in genome-wide association studies. The type 2 diabetes nonsynonymous single nucleotide polymorphism (SNP) affecting aa325 lies within the region of highest ZnT8 autoantibody (ZnT8A) binding, prompting an investigation of its relationship to type 1 diabetes. RESEARCH DESIGN AND METHODS—ZnT8A radioimmunoprecipitation assays were performed in 421 new-onset type 1 diabetic Caucasians using COOH-terminal constructs incorporating the known human aa325 variants (Trp, Arg, and Gln). Genotypes were determined by PCR-based SNP analysis. RESULTS—Sera from 224 subjects (53%) were reactive to Arg325 probes, from 185 (44%) to Trp325probes, and from 142 (34%) to Gln325probes. Sixty subjects reacted only with Arg325 constructs, 31 with Trp325 only, and 1 with Gln325 only. The restriction to either Arg325 or Trp325 corresponded with inheritance of the respective C- or T-alleles. A strong gene dosage effect was also evident because both Arg- and Trp-restricted ZnT8As were less prevalent in heterozygous than homozygous individuals. The SLC30A8 SNP allele frequency (75% C and 25% T) varied little with age of type 1 diabetes onset or the presence of other autoantibodies. CONCLUSIONS—The finding that diabetes autoimmunity can be defined by a single polymorphic residue has not previously been documented. It argues against ZnT8 autoimmunity arising from molecular mimicry and suggests a mechanistic link between the two major forms of diabetes. It has implications for antigen-based therapeutic interventions because the response to ZnT8 administration could be protective or immunogenic depending on an individual's genotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIG. 1. Relationship between autoantibody responses to Arg325, Trp325, and Gln325 constructs. A: Venn diagram illustrating the overlap of antibody detection with each of the polymorphic probes in the entire population (n = 421) in the study. The prevalence in each sector is expressed as a percentage of the population total. B–D: Assays were performed on the same set of 117 new-onset type 1 diabetic individuals and stratified as indicated; the numbers in each sector are shown in parentheses. The cutoff for positive responses was set at 0.05 (vertical and horizontal lines). Responses judged to be equivalent are set by the boundaries indicated by the angled lines, which correspond to a 3-SD excursion from the diagonal, assuming an intrassay coefficient of variation of 12.5% for each sample. Data are expressed as the immunoprecipitation index (sample-control)/(positive sample [BUNE]-control).](https://figures.cochat.ai/paper-figures/0d1ac58b771442ef8b3af5b2564a5c49/a-common-nonsynonymous-single-nucleotide-polymorphism-in-the-slc30a8-gene-figure-1.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Islet cell autoantibodies comprise autoantibodies to islet cell cytoplasm (ICA), to native insulin [referred to as “insulin autoantibodies” (IAA) ( 286 and IA-2bA (also known as phogrin) (291)], and to three variants of zinc transporter 8 (ZnT8A) (292,293).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [293]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993 · cited 1×
“The relationship between ZnT8 autoantibody reactivity and genetic variation at the SLC30A8 locus was examined using the SNP (rs13266634) encoding the Arg/Trp325 variant and two adjacent noncoding SNPs identified in a type 2 diabetes genome-wide association study (6), rs2466295, located 259 bp distally in the 3 UTR, an…”
MethodGenome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194
The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
Wenzlau, J. M., Juhl, K., Yu, L., Moua, O., Sarkar, S. A., Gottlieb, P., Rewers, M., Eisenbarth, G. S., Jensen, J., Davidson, H. W., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705894104 · Cited by 1,014
Self-citationDiabetes induced by Coxsackie virus: Initiation by bystander damage and not molecular mimicry
Horwitz, M. S., Bradley, L. M., Harbertson, J., Krahl, T., Lee, J., & Sarvennick, N. (1998) · Nature Medicine · doi:10.1038/nm0798-781 · Cited by 669
Environmental Triggers and Determinants of Type 1 Diabetes
Knip, M., Veijola, R., Virtanen, S. M., Hyöty, H., Vaarala, O., & Åkerblom, H. K. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s125 · Cited by 495
Chimienti, F., Devergnas, S., Favier, A., & Seve, M. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2330 · Cited by 470 · cited 1×
“It is encoded by SLC30A8, one of nine human genes for multispanning transmembrane proteins facilitating Zn(2) efflux from the cell and sequestration into intracellular compartments (4,5).”
BackgroundRewers, M., Bugawan, T. L., Norris, J. M., Blair, A., Beaty, B., Hoffman, M., McDuffie, R. S., Hamman, R. F., Klingensmith, G., Eisenbarth, G. S., et al. (1996) · Diabetologia · doi:10.1007/s001250050514 · Cited by 422 · cited 1×
“1% Hispanic) were parents and children in the Diabetes Autoimmunity Study in the Young (DAISY) general population cohort and parents of the sibling/offspring cohort (13).”
BackgroundSelf-citationA Novel Family of Ubiquitous Heavy Metal Ion Transport Proteins
Paulsen, I. T., & Jr., M. H. S. (1997) · Journal of Membrane Biology · doi:10.1007/s002329900192 · Cited by 392 · cited 1×
“The COOH-terminal domain of ZnT8 to which type 1 diabetes autoantibodies bind (3) incorporates a conserved protein fold found in the large family of cation diffusion facilitator efflux carriers and has orthologs in all cellular organisms (15).”
Background
Cited by
Katsarou, A., Gudbjörnsdottir, S., Rawshani, A., Dabelea, D., Bonifacio, E., Anderson, B. J., Jacobsen, L. M., Schatz, D. A., & Lernmark, Å. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.16 · Cited by 1,475
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.161596 · Cited by 1,360
“and IA-2bA (also known as phogrin) (291)], and to three variants of zinc transporter 8 (ZnT8A) (292,293).”
Kambe, T., Tsuji, T., Hashimoto, A., & Itsumura, N. (2015) · Physiological Reviews · doi:10.1152/physrev.00035.2014 · Cited by 1,158
“The cytosolic COOH-terminal portion, which is important for Early endosomes Insulin granules (pancreatic β cells) Secretory vesicles (mammary epithelial cells) Endosomes/Lysosomes ZnT8 Nucleus ER Golgi apparatus TGN ZnT10 ZnT5-ZnT6 ZnT7 ZnT10 ZnT4 ZIP1 ZIP2 ZIP3 ZIP4 ZIP5 ZIP6 ZIP8 ZIP9 ZIP10 ZIP12 ZIP14 ZnT4 ZnT2 ZnT…”
BackgroundZinc as a Gatekeeper of Immune Function
Wessels, I., Maywald, M., & Rink, L. (2017) · Nutrients · doi:10.3390/nu9121286 · Cited by 747
“Regarding T1DM, ZnT8 autoantibodies are present in 60–80% of patients at the onset of clinical disease [319,323,324].”
BackgroundMammalian Zinc Transporters: Nutritional and Physiologic Regulation
Lichten, L. A., & Cousins, R. J. (2009) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-033009-083312 · Cited by 741
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Diabetes Care · doi:10.2337/dc11-9998 · Cited by 718
“and IA-2bA (also known as phogrin) (291)], and to three variants of zinc transporter 8 (ZnT8A) (292,293).”
Todd, J. A. (2010) · Immunity · doi:10.1016/j.immuni.2010.04.001 · Cited by 560
Zinc and diabetes — clinical links and molecular mechanisms
Jansen, J., Karges, W., & Rink, L. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.01.009 · Cited by 439
“[232] examined the relationship between this SNP and ZnT-8 as an autoantigen and they detected that sera from new-onset type 1 diabetic Caucasians reacted with Arg and with Trp and that the restriction to either amino acid corresponded with the respective C or T alleles.”
ResultChen, B., Yu, P., Chan, W. N., Xie, F., Zhang, Y., Liang, L., Leung, K. T., Lo, K. W., Yu, J., Tse, G. M. K., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01679-y · Cited by 420
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
“and IA-2bA (also known as phogrin) (291)], and to three variants of zinc transporter 8 (ZnT8A) (292,293).”
Lemaire, K., Ravier, M. A., Schraenen, A., Creemers, J. W. M., Van de Plas, R., Granvik, M., Van Lommel, L., Waelkens, E., Chimienti, F., Rutter, G. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906587106 · Cited by 330
Solute carrier transporters: the metabolic gatekeepers of immune cells
Song, W., Li, D., Tao, L., Luo, Q., & Chen, L. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.12.006 · Cited by 256
Current understanding of ZIP and ZnT zinc transporters in human health and diseases
Kambe, T., Hashimoto, A., & Fujimoto, S. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1617-0 · Cited by 250
Latent Autoimmune Diabetes in Adults
Naik, R. G., Brooks-Worrell, B. M., & Palmer, J. P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1120 · Cited by 249
Enterovirus Infection and Progression From Islet Autoimmunity to Type 1 Diabetes
Stene, L. C., Oikarinen, S., Hyöty, H., Barriga, K. J., Norris, J. M., Klingensmith, G., Hutton, J. C., Erlich, H. A., Eisenbarth, G. S., & Rewers, M. (2010) · Diabetes · doi:10.2337/db10-0866 · Cited by 223
“ZnT8 autoantibodies were measured in John Hutton’s laboratory, as previously described, using a dimeric construct incorporating monomeric forms of the COOH-terminus with the polymorphic 325 Arg and Trp variants joined by a flexible linker (23,24).”
Self-citationAntigen Targets of Type 1 Diabetes Autoimmunity
Roep, B. O., & Peakman, M. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007781 · Cited by 210
Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk
Achenbach, P., Lampasona, V., Landherr, U., Koczwara, K., Krause, S., Grallert, H., Winkler, C., Pflüger, M., Illig, T., Bonifacio, E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1438-0 · Cited by 199
“We further show that the genotype of the SLC30A8 gene that encodes variants of a ZnT8 COOH-terminal epitope at aa325 [9] determines autoantibody specificity and levels and rate of progression to diabetes in ZnT8A-COOHpositive children.”
BackgroundResultInfluentialDeletion of the mouse Slc30a8 gene encoding zinc transporter-8 results in impaired insulin secretion
Pound, L. D., Sarkar, S. A., Benninger, R. K. P., Wang, Y., Suwanichkul, A., Shadoan, M. K., Printz, R. L., Oeser, J. K., Lee, C. E., Piston, D. W., et al. (2009) · Biochemical Journal · doi:10.1042/bj20090530 · Cited by 167
Self-citationSacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 203
“and IA-2bA (also known as phogrin) (291)], and to three variants of zinc transporter 8 (ZnT8A) (292,293).”
Autoimmune Markers in Diabetes
Winter, W. E., & Schatz, D. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.148205 · Cited by 158
Anti-Islet Autoantibodies in Type 1 Diabetes
Kawasaki, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210012 · Cited by 166
“In particular, the amino acid residue 325 (R325W) defined by the SLC30A8 polymorphism is critical for humoral autoimmunity to this autoantigen, and binding of ZnT8A against two isotypes (ZnT8-325R, ZnT8-325W) depends on the patient’s SLC30A8 genotype [55,56].”
Larman, H. B., Laserson, U., Querol, L., Verhaeghen, K., Solimini, N. L., Xu, G. J., Klarenbeek, P. L., Church, G. M., Hafler, D. A., Plenge, R. M., et al. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.01.013 · Cited by 126
“A chimeric ZnT8 protein (gene SEC30A8 is a chimeric construct of two peptides, amino acids 268e369) was used for RIA and contains both CR and CW variants [13].”
MethodLampasona, V., & Liberati, D. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0738-2 · Cited by 140
Eisenbarth, G. S. (2010) · Diabetes · doi:10.2337/db09-1855 · Cited by 118
Self-citationZinc transporters and dysregulated channels in cancers
Pan, Z., Choi, S., Ouadid-Ahidouch, H., Yang, J.-M., Beattie, J. H., & Korichneva, I. (2016) · Frontiers in bioscience · doi:10.2741/4507 · Cited by 110
“For example, ZnT8 with a single-nucleotide polymorphism (SNP) has been shown to be associated with increased risk of both type 1 and type 2 diabetes mellitus (14-19) and a ZIP4 mutation results in acrodermatitis enteropathica (20-24).”
BackgroundMolecular Architecture and Function of ZnT Transporters
Kambe, T. (2012) · Current topics in membranes · doi:10.1016/b978-0-12-394390-3.00008-2 · Cited by 108
Islet Autoantigens: Structure, Function, Localization, and Regulation
Arvan, P., Pietropaolo, M., Ostrov, D. A., & Rhodes, C. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007658 · Cited by 107
“2010)—but also associated with T1D (Wenzlau et al. 2008b).”
BackgroundThe diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese
Yang, L., Luo, S., Huang, G., Peng, J., Li, X., Yan, X., Lin, J., Wenzlau, J. M., Davidson, H. W., Hutton, J. C., et al. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1128 · Cited by 103
Self-citationGrijse, D. (2010) · doi:10.1007/s00125-009-1618-y · Cited by 94
“Autoantibodies against the carboxy-terminal intracellular domain of ZnT8 (ZnT8A) have been proposed as additional markers of rapid disease progression [13], but their epitope specificity has been shown to vary according to a non-synonymous single nucleotide polymorphism at codon 325 of SLC30A8, the gene encoding ZnT8…”
BackgroundMethodZinc signalling and subcellular distribution: emerging targets in type 2 diabetes
Mocchegiani, E., Giacconi, R., & Malavolta, M. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.08.002 · Cited by 100
Vermeulen, I., Weets, I., Asanghanwa, M., Ruige, J. B., Gaal, L. V., Mathieu, C., Keymeulen, B., Lampasona, V., Wenzlau, J. M., Hutton, J. C., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2268 · Cited by 100
“The strengths of this study are the registry-based recruitment of representative insulin-requiring new-onset diabetic patients over a large age range (3) and the use of multivariate analysis on the group of participants with a complete data set with centrally determined genetic and immune markers including a sensitive…”
MethodSelf-citationZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset
Vaziri‐Sani, F., Oak, S. A., Radtke, J. R., Lernmark, Å., Lynch, K. F., Agardh, C. D., Cilio, C., Lethagen, Å., Örtqvist, E., Landin‐Olsson, M., et al. (2010) · Autoimmunity · doi:10.3109/08916930903555927 · Cited by 88
Novel Diabetes Autoantibodies and Prediction of Type 1 Diabetes
Wenzlau, J. M., & Hutton, J. C. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0405-9 · Cited by 102
Self-citationThe genetic basis for type 1 diabetes
Mehers, K. L., & Gillespie, K. M. (2008) · British Medical Bulletin · doi:10.1093/bmb/ldn045 · Cited by 83
The environment and the origins of islet autoimmunity and Type 1 diabetes
Regnell, S. E., & Lernmark, Å. (2012) · Diabetic Medicine · doi:10.1111/dme.12099 · Cited by 101
Anand, V., Li, Y., Liu, B., Ghalwash, M., Koski, E., Ng, K., Dunne, J. L., Jönsson, J., Winkler, C., Knip, M., et al. (2021) · Diabetes Care · doi:10.2337/dc20-1836 · Cited by 83
No association of multiple type 2 diabetes loci with type 1 diabetes
Raj, S. M., Howson, J. M. M., Walker, N. M., Cooper, J. D., Smyth, D. J., Field, S. F., Stevens, H. E., & Todd, J. A. (2009) · Diabetologia · doi:10.1007/s00125-009-1391-y · Cited by 81
“They also reported that antibodies to ZnT8 are detectable at a very young age in type 1 diabetic patients, frequently before 3 years [33].”
BackgroundInfluentialWenzlau, J. M., Walter, M., Gardner, T. J., Frisch, L. M., Yu, L., Eisenbarth, G. S., Ziegler, A.-G., Davidson, H. W., & Hutton, J. C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0169 · Cited by 74
Self-citationAdvances in Type 1 Diabetes Prediction Using Islet Autoantibodies: Beyond a Simple Count
So, M., Speake, C., Steck, A. K., Lundgren, M., Colman, P. G., Palmer, J. P., Herold, K. C., & Greenbaum, C. J. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab013 · Cited by 80
Kawasaki, E., Uga, M., Nakamura, K., Kuriya, G., Satoh, T., Fujishima, K., Ozaki, M., Abiru, N., Yamasaki, H., Wenzlau, J. M., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-1165-y · Cited by 72
“The first two points were recently proven in US patients [ 7 ].”
BackgroundSelf-citationZnt7-null Mice Are More Susceptible to Diet-induced Glucose Intolerance and Insulin Resistance
Huang, L., Kirschke, C. P., Lay, Y.-A. E., Levy, L. B., Lamirande, D. E., & Zhang, P. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.309666 · Cited by 73
Pound, L. D., Sarkar, S. A., Ustione, A., Dadi, P. K., Shadoan, M. K., Lee, C. E., Walters, J. A., Shiota, M., McGuinness, O. P., Jacobson, D. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040972 · Cited by 72
“Interestingly, ZnT-8 is also an autoantigen in type 1 diabetes and this same polymorphism, which results in an arginine to tryptophan mutation at amino acid residue 325, has also been shown to affect autoantibody epitope specificity [16].”
Self-citationVaziri-Sani, F., Delli, A. J., Elding-Larsson, H., Lindblad, B., Carlsson, A., Forsander, G., Ivarsson, S. A., Ludvigsson, J., Marcus, C., & Lernmark, Å. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2011.06.011 · Cited by 69
“ZnT8A were detected in 63% of newly diagnosed T1D patients, but also in 3% of T2D patients and 3% of healthy controls (Wenzlau et al., 2008b).”
BackgroundHarmonization of immunoassays for biomarkers in diabetes mellitus
Hörber, S., Achenbach, P., Schleicher, E. D., & Peter, A. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.02.015 · Cited by 83
“A principle epitope targeted by ZnT8A is influenced by the single amino acid at position 325 encoded as arginine, tryptophan, or glutamine by different polymorphic variants of the ZnT8-encoding gene SLC30A8 (Wenzlau et al., 2008).”
BackgroundZnT8 and type 1 diabetes [Review]
Kawasaki, E. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0069 · Cited by 70
Zinc transporters and their role in the pancreatic β‐cell
Lemaire, K., Chimienti, F., & Schuit, F. C. (2012) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2012.00199.x · Cited by 68
Salonen, K. M., Ryhänen, S. J., Härkönen, T., Ilonen, J., Knip, M., & Register, F. P. D. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2440 · Cited by 70
“In subsequent studies, the addition of ZnT8A to a panel including the four traditional diabetes-associated autoantibodies has been shown to increase the positive predictive value for T1D [9,10].”
BackgroundResultInfluentialKawasaki, E., Nakamura, K., Kuriya, G., Satoh, T., Kobayashi, M., Kuwahara, H., Abiru, N., Yamasaki, H., Matsuura, N., Miura, J., et al. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.10.007 · Cited by 64
“2 Humoral autoreactivity to ZnT8 aa325 variants We and others reported that the amino acid encoded by the polymorphic codon 325 is a key determinant and there are three classes of conformational epitopes: one for which 325Arg is an essential determinant, a second that is 325Trp-restricted, and a third that is not affe…”
BackgroundVendrame, F., Hopfner, Y. Y., Diamantopoulos, S., Virdi, S. K., Allende, G., Snowhite, I., Reijonen, H., Chen, L. J., Ruiz, P., Ciancio, G., et al. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13426 · Cited by 54
“SLC30A8 polymorphisms affect the amino acid sequence at residue 325, an essential determinant of antigenicity (32).”
BackgroundSelf-citationfor the Swedish Better Diabetes Diagnosis Study Group, Carlsson, A., Kockum, I., Lindblad, B., Engleson, L., Nilsson, A., Forsander, G., Karlsson, A.-K., Kernell, A., Ludvigsson, J., et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.122 · Cited by 62
Novel antigens in type 1 diabetes: The importance of ZnT8
Wenzlau, J. M., Frisch, L. M., Gardner, T. J., Sarkar, S. A., Hutton, J. C., & Davidson, H. W. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0019-4 · Cited by 65
Self-citationAdvances in the Prediction and Natural History of Type 1 Diabetes
Bonifacio, E., & Ziegler, A. G. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.05.007 · Cited by 61
Masala, S., Paccagnini, D., Cossu, D., Brezar, V., Pacifico, A., Ahmed, N., Mallone, R., & Sechi, L. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026931 · Cited by 67
“Of further note, the transmembrane region identified here does not comprise the polymorphic ZnT8 R/W variant at position 325, which is located in the last extra-luminal domain, thus making it unlikely that the ZnT8 genetic background may shape these Ab reactivities, as described for conventional anti-ZnT8 aAbs [25].”
BackgroundRising incidence of type 1 diabetes is associated with altered immunophenotype at diagnosis
Long, A. E., Gillespie, K. M., Rokni, S., Bingley, P. J., & Williams, A. J. K. (2012) · Diabetes · doi:10.2337/db11-0962 · Cited by 60
“recognizing either arginine (ZnT8RA) or tryptophan (ZnT8WA) at position 325 (15).”
BackgroundGlycotoxin and Autoantibodies Are Additive Environmentally Determined Predictors of Type 1 Diabetes
Beyan, H., Riese, H., Hawa, M. I., Beretta, G., Davidson, H. W., Hutton, J. C., Burger, H., Schlosser, M., Snieder, H., Boehm, B. O., et al. (2012) · Diabetes · doi:10.2337/db11-0971 · Cited by 70
“In family studies, those with high-risk HLA genes show diabetes-associated autoantibodies earlier, while ZnT8A is associated with specific genetic susceptibility (7,22).”
Self-citationBirth and coming of age of islet autoantibodies
Bonifacio, E. E., & Achenbach, P. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13360 · Cited by 66
“In contrast, the β-cell zinc transporter 8 (ZnT8) protein has been confirmed to be a target of autoantibodies (ZnT8A) in over 50% of patients with type 1 diabetes [50, 51], and tetraspanin 7 was identified as the 38-kDa target of autoantibodies against glima”
BackgroundNiechciał, E., Rogowicz‐Frontczak, A., Piłaciński, S., Fichna, M., Skowrońska, B., Fichna, P., & Zozulińska‐Ziółkiewicz, D. (2018) · Acta Diabetologica · doi:10.1007/s00592-017-1091-x · Cited by 47
Genetic association of zinc transporter 8 (ZnT8) autoantibodies in type 1 diabetes cases
Howson, J. M. M., Krause, S. W., Stevens, H. E., Smyth, D. J., Wenzlau, J. M., Bonifacio, E. E., Hutton, J. C., Ziegler, A., Todd, J. A., & Achenbach, P. (2012) · Diabetologia · doi:10.1007/s00125-012-2540-2 · Cited by 50
“Analysis of the two epitopes, ZnT8WA and ZnT8RA, revealed that the T allele at rs13266634 was associated with ZnT8WA positivity (p09.”
BackgroundSelf-citationAndersson, C., Kolmodin, M., Ivarsson, S.-A., Carlsson, A., Forsander, G., Lindblad, B., Ludvigsson, J., Kockum, I., Marcus, C., Samuelsson, U., et al. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12093 · Cited by 44
Different role of zinc transporter 8 between type 1 diabetes mellitus and type 2 diabetes mellitus
Yi, B., Huang, G., & Zhou, Z. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12441 · Cited by 43
Pound, L. D., Hang, Y., Sarkar, S. A., Wang, Y., Milam, L. A., Oeser, J. K., Printz, R. L., Lee, C. E., Stein, R. W., Hutton, J. C., et al. (2010) · Biochemical Journal · doi:10.1042/bj20101488 · Cited by 44
Self-citationAutoimmunity against INS-IGF2 Protein Expressed in Human Pancreatic Islets*
Kanatsuna, N., Taneera, J., Vaziri‐Sani, F., Wierup, N., Larsson, H. E., Delli, A. J., Skärstrand, H., Balhuizen, A., Bennet, H., Steiner, D. F., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.478222 · Cited by 45
Immunology of β-Cell Destruction
Torre, D. L., & Lernmark, Å. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_24 · Cited by 49
The C‐terminal cytosolic domain of the human zinc transporter ZnT8 and its diabetes risk variant
Parsons, D. S., Högstrand, C., & Maret, W. (2018) · FEBS Journal · doi:10.1111/febs.14402 · Cited by 40
Long, A. E., Wilson, I. V., Becker, D. J., Libman, I. M., Arena, V. C., Wong, F. S., Steck, A. K., Rewers, M., Yu, L., Achenbach, P., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4591-5 · Cited by 44
“DAISY, USA DAISY has followed two cohorts of young children at increased risk of type 1 diabetes (total n = 2547); a cohort of relatives of individuals with type 1 diabetes (siblings and offspring) and a newborn high genetic risk general population cohort from the Denver area [13, 16, 17].”
BackgroundSelf-citationTargeting the Zinc Transporter ZIP7 in the Treatment of Insulin Resistance and Type 2 Diabetes
Adulcikas, J., Sonda, S., Norouzi, S., Sohal, S. S., & Myers, S. (2019) · Nutrients · doi:10.3390/nu11020408 · Cited by 41
“Similarly, studies in Japanese patients with T1DM identified ZnT8 autoantibodies in 58% of patients with acute-onset and in 20% with slow-onset T1DM [92].”
BackgroundInfluentialPresence of diabetes autoantigens in extracellular vesicles derived from human islets
Hasilo, C. P., Negi, S., Allaeys, I., Cloutier, N., Rutman, A. K., Gasparrini, M., Bonneil, É., Thibault, P., Boilard, É., & Paraskevas, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-04977-y · Cited by 39
Juusola, M., Parkkola, A., Härkönen, T., Siljander, H., Ilonen, J., Åkerblom, H. K., Knip, M., & the Childhood Diabetes in Finland Study Group (2015) · Diabetes Care · doi:10.2337/dc15-1027 · Cited by 38
“Autoantibody Assays Serum ZnT8A levels were analyzed by a radiobinding assay as described earlier (4,5).”
MethodImportance of Zinc Transporter 8 Autoantibody in the Diagnosis of Type 1 Diabetes in Latin Americans
Gomes, K. F. B., Semzezem, C., Batista, R., Fukui, R. T., Santos, A. S., Correia, M. R. S., Passos‐Bueno, M. R., & da Silva, M. E. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-00307-4 · Cited by 38
What has zinc transporter 8 autoimmunity taught us about type 1 diabetes?
Williams, C. L., & Long, A. E. (2019) · Diabetologia · doi:10.1007/s00125-019-04975-x · Cited by 39
“Overall, several international studies have shown that around two-thirds of children are ZnT8A positive at diagnosis [32, 46]; depending on the age group considered, the prevalence is similar to IA-2A.”
InfluentialFabris, M., Zago, S., Liguori, M., Trevisan, M. T., Zanatta, M., Comici, A., Zanette, G., Carlin, E., Curcio, F., & Tonutti, E. (2015) · Autoimmunity Highlights · doi:10.1007/s13317-015-0068-4 · Cited by 36
“11 and presents a polymorphism at position 325 (Arg325Trp) [11], which could influence also the development of ZnT8 immunogenicity and the phenotypic features of paediatric T1D [12, 13] and adultonset type 2 diabetes [14], indicating that this amino acid substitution has the critical role in antibody binding [15].”
Petruželková, L., Ananieva-Jordanova, R., Včeláková, J., Vesely, Z., Štechová, K., Lebl, J., Dušátková, P., Šumník, Z., Coles, R., Powell, M., et al. (2013) · Diabetic Medicine · doi:10.1111/dme.12308 · Cited by 39
Wan, H., Merriman, C., Atkinson, M. A., Wasserfall, C. H., MCGRAIL, K. M., Liang, Y., Fu, D., & Dai, H. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711169114 · Cited by 34
“A major arginine variation at position 325 (325R) of human ZnT8 is an immunoreactivity determinant for ZnT8A (17).”
BackgroundBosco, M. D., Mohanasundaram, D. M., Drogemuller, C., Lang, C. J., Zalewski, P., & Coates, P. (2010) · The review of diabetic studies : RDS · doi:10.1900/rds.2010.7.263 · Cited by 38
“Population studies revealed a strong association of single nucleotide polymorphism (SNP) RS13266634, a nonsynonymous [92] arg325Trp (C>T) variant in SLC30A8 with type 2 diabetes [100-102].”
BackgroundDeNiro, M., & Al-Mohanna, F. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050360 · Cited by 34
“{325}) [16], was subsequently shown to be associated with the presence of altered glucose homeostasis, pancreatic b cell”
Brorsson, C., Vaziri‐Sani, F., Bergholdt, R., Eising, S., Nilsson, A., Svensson, J., Lernmark, Å., Pociot, F., & the Danish Study Group of Childhood Diabetes (2010) · Autoimmunity · doi:10.3109/08916934.2010.509120 · Cited by 33
“Previous studies have reported an increasing prevalence of ZnT8A with increasing age in children followed before disease onset [4,12], as well as with AAD [4,10], which is in concordance with our data.”
BackgroundResultInfluentialFrom Genetic Association to Molecular Mechanism
van de Bunt, M., & Gloyn, A. L. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0150-2 · Cited by 37
“Since this first report the R325W variant has also been shown to be associated with autoantibody epitope specificity changes in T1D [30].”
BackgroundMasala, S., Cossu, D., Piccinini, S., Rapini, N., Massimi, A., Porzio, O., Pietrosanti, S., Lidano, R., Bitti, M. L. M., & Sechi, L. A. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0558-2 · Cited by 30
Nielsen, L. B., Vaziri‐Sani, F., Pörksen, S., Andersen, M.-L. M., Svensson, J., Bergholdt, R., Pociot, F., Hougaard, P., de Beaufort, C. E., Castaño, L. A., et al. (2011) · Autoimmunity · doi:10.3109/08916934.2011.576724 · Cited by 30
“A relation between age-at-onset and positivity for ZnT8RAb was previously indicated in a mixed cohort of children and adults, in which the prevalence of ZnT8Ab was low in the very young children but increased dramatically from 3 years onward, peaked at 80% in late adolescence, and tended to decline thereafter [2].”
BackgroundUnderstanding Islet Autoantibodies in Prediction of Type 1 Diabetes
Jia, X., & Yu, L. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad160 · Cited by 35
“As compelling evidence of the autoimmune pathogenesis of T1D, the presence of islet autoantibodies (IAbs) plays a crucial role in supporting the diagnosis of T1D [5-11].”
BackgroundSelf-citationSex as a determinant of type 1 diabetes at diagnosis
Turtinen, M., Härkönen, T., Parkkola, A., Ilonen, J., Knip, M., & Register, T. F. P. D. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12697 · Cited by 35
Cooper, J. D., Walker, N. M., Healy, B. C., Smyth, D. J., Downes, K., & Todd, J. A. (2009) · Genes and Immunity · doi:10.1038/gene.2009.98 · Cited by 29
Current and Future Clinical Applications of Zinc Transporter-8 in Type 1 Diabetes Mellitus
Yi, B., Huang, G., & Zhou, Z. (2015) · Chinese Medical Journal · doi:10.4103/0366-6999.163389 · Cited by 31
“The features of ZnT8A As discussed above, autoantibodies against ZnT8‐325W and/or ZnT8‐325R (ZnT8A‐325R and/or ZnT8A‐325W) contribute to the most ZnT8A positivity in T1DM patients.[32,34,43] The prevalence and titer of ZnT8A‐325R were significantly associated with T1DM patients carrying a C allele (CC + CT).”
BackgroundInfluentialAndersen, M. K., Härkönen, T., Forsblom, C. M., Groop, P., Knip, M., & Tuomilehto, J. (2012) · Autoimmunity · doi:10.3109/08916934.2012.741155 · Cited by 31
“The fact that the association of SLC30A8 genotype with ZnT8A specificity, previously shown in childhood diabetes [11], was evident only among adult patients with type 1 diabetes further supports the notion of different autoimmune Table 2.”
BackgroundMethodXu, G., Kang, D., Zhang, C., Lou, H. P., Sun, C., Yang, Q., Lü, L., Xu, G., Zhang, J., & Wang, F. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18093 · Cited by 27
Screening of ZnT8 autoantibodies in the diagnosis of autoimmune diabetes in a large French cohort
Garnier, L., Marchand, L., Benoit, M., Nicolino, M. P., Bendelac, N., Wright, C. C., Moulin, P., Lombard, C., Thivolet, C. H., & Fabien, N. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.12.043 · Cited by 27
Andersen, M. L. M., Vaziri‐Sani, F., Delli, A. J., Pörksen, S., Jacobssen, E., Thomsen, J. F., Svensson, J., Petersen, J. S., Hansen, L. B., Lernmark, Å., et al. (2012) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2012.00857.x · Cited by 26
“Furthermore, this article shows that TT carriers of the rs13266624 SNP of the SLC30A8 gene (7, 29) have a more rapid decline in stimulated C-peptide compared to the CC and CT.”
BackgroundKawasaki, E., Nakamura, K., Kuriya, G., Satoh, T., Kobayashi, M., Kuwahara, H., Abiru, N., Yamasaki, H., Matsuura, N., Miura, J., et al. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1269 · Cited by 26
Extrapancreatic Autoantibody Profiles in Type I Diabetes
Burbelo, P. D., Lebovitz, E. E., Bren, K. E., Bayat, A., Paviol, S., Wenzlau, J. M., Barriga, K. J., Rewers, M., Harlan, D. M., & Iadarola, M. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045216 · Cited by 27
“For these tests, 6 different b-cell targets were examined including GAD65, IA2, IA2-b and 3 different ZnT8 subtypes [34].”
BackgroundSelf-citationWenzlau, J. M., Frisch, L. M., Hutton, J. C., Fain, P. R., & Davidson, H. W. (2015) · Diabetes Care · doi:10.2337/dcs15-2004 · Cited by 29
“This residue determines the binding specificity of a subset of ZnT8A (14).”
BackgroundSelf-citationTolerogenic Nanoparticles to Treat Islet Autoimmunity
Neef, T., & Miller, S. D. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0914-z · Cited by 28
Antigen-specific immunotherapies in type 1 diabetes
Zhang, X., Dong, Y., Liu, D., Yang, L., Xu, J., & Wang, Q. (2022) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2022.127040 · Cited by 26
Williams, C. L., Fareed, R., Mortimer, G., Aitken, R. J., Wilson, I. V., George, G., Gillespie, K. M., Williams, A. J. K., The BOX Study Group, Ballav, C., et al. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac087 · Cited by 31
“For the assessment of ZnT8A, the SLC30A8 SNP (rs13266634; n = 383) that determines two major epitopes of ZnT8A was considered [28].”
BackgroundGu, Y., Merriman, C., Guo, Z., Jia, X., Wenzlau, J. M., Li, H., Li, H., Rewers, M., Yu, L., & Fu, D. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102677 · Cited by 27
“Since ZnT8ec epitopes on the surface of TMD is independent of polymorphic variations in CTD, a bona fide ZnT8ecA is expected to cross-react with both ZnT8-R and ZnT8-W antigens.”
BackgroundSelf-citationLo, B., Swafford, A. D.-E., Shafer-Weaver, K., Jerome, L. F., Rakhlin, L., Mathern, D. R., Callahan, C. A., Jiang, P. D., Davison, L. J., Stevens, H. E., et al. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-203 · Cited by 27
“Although not an active component of the disease process itself, the presence of circulating autoantibodies to two or more islet antigens, namely insulin (IAA), glutamic acid decarboxylase (GADA), islet antigen 2 (IA-2A), and zinc transporter-8 (ZnT8A), is highly predictive when combined with a family history of the di…”
BackgroundAntigenicity and Epitope Specificity of ZnT8 Autoantibodies in Type 1 Diabetes
Skärstrand, H., Lernmark, Å., & Vaziri‐Sani, F. (2012) · Scandinavian Journal of Immunology · doi:10.1111/sji.12008 · Cited by 24
Nayak, D. K., Calderón, B., Vomund, A. N., & Unanue, E. R. (2014) · Diabetes · doi:10.2337/db13-1882 · Cited by 25
Mohanasundaram, D., Drogemuller, C., Brealey, J. K., Jessup, C. F., Milner, C. R., Murgia, C., Lang, C. J., Milton, A. G., Zalewski, P. D., Russ, G. R., et al. (2011) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2011.07.004 · Cited by 23
“Recent genome wide association studies demonstrated a link between several single nucleotide polymorphisms (SNP) of the ZnT8 gene and the development of human type II diabetes [27,39] and one of these SNP’s (Arg325Trp) was later confirmed as an auto antigen in human type I diabetes [38].”
BackgroundAsanghanwa, M., Gorus, F., Weets, I., der Auwera, B. J. R. V., Aminkeng, F., Mbunwe, E., Goubert, P., Verhaeghen, K., Sobngwi, E., Wenzlau, J. M., et al. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.013 · Cited by 24
“University of Colorado at Denver as previously described [19].”
BackgroundMethodSelf-citationMapping of conformational autoantibody epitopes in ZNT8
Wenzlau, J. M., Frisch, L. M., Hutton, J. C., & Davidson, H. W. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1266 · Cited by 24
“are expressed as an index relative to the positive control [11].”
BackgroundSelf-citation
Metadata
- Authors
- Wenzlau, J. M., Liu, Y., Yu, L., Moua, O., Fowler, K. T., Rangasamy, S., Walters, J., Eisenbarth, G. S., Davidson, H. W., & Hutton, J. C.
- Affiliations
- University of Colorado Denver (US)
- Jiangsu Province Hospital (CN)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-10-01
- Volume
- 57
- Issue
- 10
- Pages
- 2693-2697
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2551679
- OpenAlex
- W2134857194
- Cited by
- 205
- References
- 24
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 7 · 2023: 9 · 2022: 8 · 2021: 5 · 2020: 7 · 2019: 10 · 2018: 10 · 2017: 10 · 2016: 12 · 2015: 14 · 2014: 16 · 2013: 12 · 2012: 23
- FWCI
- 10.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association (P30 DK57516)
- National Institutes of Health (NIH-R01, NIH R01 DK052068, DK052068, DK57516)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK057516, P30 DK 57516, R01DK052068)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- SLC30A8, zinc transporter 8, ZnT8 autoantibodies, type 1 diabetes, type 2 diabetes, non-synonymous single nucleotide polymorphisms, autoantibody specificity, gene dosage effect, molecular mimicry, autoimmunity
- MeSH terms
- Zinc Transporter 8, Adolescent, Adult, Antibody Specificity, Autoantibodies, Child, Child, Preschool, Diabetes Mellitus, Type 1, Genotype, Humans, Infant, Middle Aged, Polymerase Chain Reaction, Polymorphism, Single Nucleotide, Cation Transport Proteins, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.